Miltefosine gel for skin sores from leishmaniasis
Treatments studied
Part of Infections, Skin clinical trials.
This study tests a gel containing miltefosine (a medicine) applied directly to the skin sores caused by cutaneous leishmaniasis. The goal is to see if the gel is safe and works to clear the sores.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a confirmed diagnosis of cutaneous leishmaniasis (a skin infection caused by a parasite).
- You must have 1 to 4 skin sores, each about 1 to 4 cm in size, that have been present for more than a month, and they must NOT be on your face, ears, or joints.
- You must not have the more serious forms of leishmaniasis (like mucosal or widespread disease).
- You must not have had oral or injected anti-leishmaniasis treatment in the last 8 weeks, and you must not have failed earlier local treatments.
- You cannot be pregnant or breastfeeding, and if you are of childbearing age, you must agree to use contraception during and for 45 days after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether applying a heat pack to skin sores caused by cutaneous leishmaniasis can help treat them. It's for people who cannot take the standard medication or prefer a non-drug option.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
This trial tests whether injecting the antibiotic levofloxacin directly into sores caused by Leishmania parasites can help heal them. It might be an option if you have a few sores and haven't recently been treated for this infection.
This study tests whether an injection of ciprofloxacin (an antibiotic) directly into skin sores can treat cutaneous leishmaniasis as effectively as the standard medicine, sodium stibogluconate. It may be an option if you have a small number of sores and have not been treated recently.
This study tests if an injection of the antibiotic metronidazole directly into skin sores can help heal leishmaniasis, a parasite infection from sandfly bites. It's for people with fewer than seven sores.
This trial tests how well miltefosine works for people with leishmaniasis, a skin infection from a parasite. It aims to find the best way to use this medicine to help patients get better.
Hear when a new Cutaneous Leishmaniasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.